IBM vs ACN vs INFY
161 measures in 16 categories, one definition each, computed from filings and market data.
IBM68.9
International Business Machines Corporation
Technology · Information Technology Services
$232.14 −0.85%$218.7B mkt cap
Score DNA
ACN70.0
Accenture plc
Technology · Information Technology Services
$229.68 +2.12%$140.6B mkt cap
Score DNA
INFY70.7
Infosys Limited
Technology · Information Technology Services
$12.24 +0.99%$49.7B mkt cap
Score DNA
Price, rebased to 100 three years ago
IBM ACN INFY · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 14 | 21 | 0 |
| Last Congress purchase | 2026-09-11 | 2026-08-28 | — |
| 13F net change in holders | +155 | −240 | −16 |
| ETFs adding shares, 30d | 1,543 | 648 | 178 |
| ETFs trimming, 30d | 1,187 | 488 | 92 |
| Net ETF funds, 30d | +356 | +160 | +86 |
Valuation
16 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| P/E (TTM) | 20.4x
75th
|
16.7x
61st
|
14.9x
46th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.28
12th
|
1.88
62nd
|
4.05
81st
|
| Price / sales | 3.2x
83rd
|
1.9x
69th
|
2.4x
75th
|
| Price / book | 6.3x
86th
|
4.5x
77th
|
5.2x
80th
|
| Price / tangible book | — | 24.2x
90th
|
5.7x
52nd
|
| Price / free cash flow | 15.7x
83rd
|
12.1x
63rd
|
13.0x
67th
|
| Price / operating cash flow | 14.7x
88th
|
11.4x
70th
|
12.1x
76th
|
| Enterprise value | $275.8B
100th
|
$141.1B
97th
|
$47.5B
92nd
|
| EV / sales | 4.0x
83rd
|
1.9x
53rd
|
2.3x
69th
|
| EV / EBITDA | 15.7x
88th
|
10.6x
53rd
|
9.3x
50th
|
| EV / EBIT | 22.3x
86th
|
12.1x
48th
|
10.4x
34th
|
| EV / free cash flow | 19.8x
83rd
|
12.1x
40th
|
12.4x
43rd
|
| Earnings yield | 4.9%
43rd
|
6.0%
54th
|
6.7%
65th
|
| FCF yield | 6.4%
32nd
|
8.3%
49th
|
7.7%
46th
|
| Operating cash flow yield | 6.8%
22nd
|
8.8%
38th
|
8.3%
32nd
|
| Graham number (per share) | $95.71
81st
|
$127.62
93rd
|
$6.55
7th
|
Profitability (TTM)
12 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| Gross margin | 58.4%
84th
|
32.0%
54th
|
30.4%
46th
|
| EBITDA margin | 25.4%
84th
|
18.0%
65th
|
25.3%
81st
|
| Operating margin | 16.9%
84th
|
15.8%
76th
|
20.3%
95th
|
| EBIT margin | 17.9%
84th
|
15.7%
73rd
|
22.6%
95th
|
| Net margin | 15.5%
89th
|
11.3%
76th
|
16.4%
92nd
|
| NOPAT margin | 17.3%
95th
|
11.8%
78th
|
14.9%
92nd
|
| FCF margin | 20.2%
86th
|
15.7%
73rd
|
18.8%
78th
|
| Operating cash flow margin | 21.5%
83rd
|
16.7%
64th
|
20.2%
75th
|
| R&D / revenue | 12.7%
92nd
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 28.8%
76th
|
16.3%
38th
|
9.8%
11th
|
| Stock comp / revenue | — | 2.8%
72nd
|
0.4%
17th
|
| Effective tax rate | -2.5%
0th
|
25.1%
67th
|
26.6%
78th
|
Returns on capital
11 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| ROE (on average equity) | 34.6%
86th
|
26.8%
73rd
|
32.1%
84th
|
| ROA | 7.1%
57th
|
12.1%
81st
|
19.7%
100th
|
| ROIC | 13.1%
62nd
|
27.3%
95th
|
40.9%
97th
|
| ROCE | 10.6%
46th
|
22.8%
84th
|
42.5%
100th
|
| Return on tangible assets | 8.2%
51st
|
16.8%
78th
|
27.1%
100th
|
| Cash ROIC (OCF / invested capital) | 16.3%
50th
|
38.5%
94th
|
55.4%
97th
|
| Gross profitability (GP / assets) | 26.7%
57th
|
32.3%
65th
|
37.6%
81st
|
| ROIC, 3-yr average | 10.4%
55th
|
25.9%
94th
|
33.1%
97th
|
| ROIC, 5-yr average | 8.3%
45th
|
38.1%
94th
|
41.7%
97th
|
| ROE, 5-yr average | 25.1%
84th
|
27.0%
91st
|
32.1%
97th
|
| Incremental ROIC | 132.9%
86th
|
53.7%
71st
|
-55.7%
23rd
|
Growth
17 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| Revenue growth (TTM YoY) | 7.9%
54th
|
6.5%
43rd
|
4.1%
37th
|
| Revenue growth (QoQ) | 7.8%
78th
|
-0.2%
19th
|
0.8%
28th
|
| Revenue CAGR, 3 yr | 4.5%
35th
|
5.0%
38th
|
3.4%
21st
|
| Revenue CAGR, 5 yr | 1.1%
17th
|
8.0%
50th
|
7.4%
40th
|
| Gross profit CAGR, 3 yr | 7.0%
52nd
|
4.6%
42nd
|
3.1%
33rd
|
| Operating income CAGR, 3 yr | 9.9%
72nd
|
9.9%
68th
|
1.9%
32nd
|
| Net income growth (TTM YoY) | 83.9%
89th
|
9.4%
61st
|
3.8%
43rd
|
| Net income CAGR, 3 yr | 74.3%
100th
|
6.9%
50th
|
3.3%
41st
|
| EPS growth (TTM YoY) | 82.7%
89th
|
13.8%
64th
|
5.2%
39th
|
| EPS CAGR, 3 yr | 72.3%
100th
|
8.9%
50th
|
3.7%
41st
|
| EPS CAGR, 5 yr | 13.8%
59th
|
8.7%
36th
|
4.6%
9th
|
| FCF growth (TTM YoY) | 18.2%
66th
|
6.9%
38th
|
-3.1%
21st
|
| FCF CAGR, 3 yr | 10.7%
56th
|
8.9%
52nd
|
13.5%
59th
|
| Operating cash flow CAGR, 3 yr | 6.6%
43rd
|
9.1%
53rd
|
11.8%
63rd
|
| Book value CAGR, 3 yr | 14.4%
88th
|
9.1%
59th
|
2.4%
34th
|
| Dividend CAGR, 3 yr | -0.6%
21st
|
4.4%
71st
|
-14.4%
7th
|
| Sustainable growth rate | 14.3%
50th
|
14.1%
46th
|
11.4%
36th
|
Margin history & stability
7 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| Gross margin, 3-yr average | 57.5%
88th
|
32.2%
53rd
|
30.3%
47th
|
| Operating margin, 3-yr average | 16.7%
79th
|
15.1%
74th
|
20.7%
94th
|
| Net margin, 3-yr average | 12.7%
88th
|
11.2%
68th
|
16.7%
97th
|
| FCF margin, 3-yr average | 19.3%
85th
|
14.8%
74th
|
19.0%
82nd
|
| Revenue stability (0-1) | 0.16
9th
|
0.96
79th
|
0.91
59th
|
| Earnings stability (0-1) | 0.38
41st
|
0.94
94th
|
0.95
97th
|
| Margin stability (0-1) | 0.95
65th
|
0.99
97th
|
0.94
53rd
|
Liquidity (latest quarter)
7 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| Cash & short-term investments | $8.1B
97th
|
$12.8B
100th
|
$3.1B
92nd
|
| Net cash (− = net debt) | −$57.1B
0th
|
−$559.2M
59th
|
$2.2B
100th
|
| Working capital | −$7.5B
0th
|
$9.5B
100th
|
$4.8B
97th
|
| Current ratio | 0.79
5th
|
1.43
49th
|
1.86
68th
|
| Quick ratio | 0.74
3rd
|
1.43
49th
|
1.86
68th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.23
32nd
|
0.58
76th
|
0.56
73rd
|
| Defensive interval (days) | 280 days
16th
|
883 days
65th
|
1,523 days
86th
|
Leverage & solvency (latest quarter)
13 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| Total debt | $65.3B
100th
|
$13.4B
92nd
|
$923.0M
38th
|
| Debt / equity | 1.89
83rd
|
0.42
31st
|
0.10
17th
|
| Net debt / equity | 1.66
81st
|
0.02
22nd
|
−0.23
6th
|
| Debt / assets | 42.9%
78th
|
18.2%
30th
|
5.6%
19th
|
| Debt / capital | 65.5%
83rd
|
29.8%
31st
|
8.8%
17th
|
| Debt / EBITDA | 3.71
75th
|
1.00
22nd
|
0.18
3rd
|
| Net debt / EBITDA | 3.25
72nd
|
0.04
22nd
|
−0.43
16th
|
| Interest coverage (EBIT / interest) | 6.4x
60th
|
38.5x
89th
|
95.8x
91st
|
| Cash interest coverage | 7.7x
54th
|
40.7x
83rd
|
86.0x
91st
|
| Debt payback (years of OCF) | 4.4 yrs
67th
|
1.1 yrs
24th
|
0.2 yrs
6th
|
| Liabilities / assets | 77.3%
78th
|
54.8%
38th
|
40.9%
19th
|
| IS credit model rating | BBB- | AA- | AA+ |
| Implied credit spread (bps) | 350
54th
|
100
19th
|
65
0th
|
Efficiency
11 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| Asset turnover | 0.46
27th
|
1.07
70th
|
1.20
73rd
|
| Fixed asset turnover | 7.85
27th
|
15.69
68th
|
9.82
35th
|
| Inventory turnover | 19.0
50th
|
— | — |
| Receivables turnover | 11.5
86th
|
4.7
32nd
|
5.5
54th
|
| Days sales outstanding | 32 days
14th
|
77 days
69th
|
66 days
47th
|
| Days inventory outstanding | 19 days
50th
|
— | — |
| Days payables outstanding | 54 days
73rd
|
21 days
43rd
|
11 days
22nd
|
| Cash conversion cycle (days) | −3 days
16th
|
56 days
73rd
|
55 days
70th
|
| Capex / revenue | 1.3%
36th
|
1.0%
28th
|
1.4%
42nd
|
| Capex / depreciation | 0.18
17th
|
0.44
44th
|
0.53
56th
|
| Operating expense ratio | 42.5%
76th
|
16.7%
27th
|
10.4%
11th
|
Cash flow & earnings quality
7 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| Operating cash flow / net income | 1.39
39th
|
1.47
43rd
|
1.24
21st
|
| FCF / net income | 1.30
50th
|
1.38
57th
|
1.15
36th
|
| FCF / operating cash flow | 93.8%
88th
|
94.0%
91st
|
93.0%
75th
|
| Capex / operating cash flow | 6.2%
12th
|
6.0%
9th
|
7.0%
25th
|
| Accruals ratio | -2.8%
78th
|
-5.7%
46th
|
-4.6%
54th
|
| Sloan accruals ratio | -6.1%
38th
|
-1.0%
65th
|
-10.8%
11th
|
| Earnings quality score (0-1) | 1.00
50th
|
0.75
7th
|
1.00
50th
|
Scores & forensic checks
15 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| IS score | 69
84th
|
70
86th
|
71
92nd
|
| IS profitability | 64
86th
|
59
81st
|
75
92nd
|
| IS growth | 66
80th
|
53
54th
|
47
34th
|
| IS value | 44
24th
|
68
62nd
|
68
57th
|
| IS momentum | 90
89th
|
80
66th
|
74
60th
|
| IS risk (safety) | 80
57th
|
90
70th
|
100
76th
|
| IS quality | 68
65th
|
82
92nd
|
87
100th
|
| IS balance sheet | 32
16th
|
80
86th
|
90
95th
|
| IS earnings quality | 74
89th
|
67
51st
|
65
43rd
|
| IS cash flow | 72
76th
|
73
84th
|
74
89th
|
| Piotroski F-score (0-9) | 6
38th
|
8
89th
|
7
73rd
|
| Altman Z-score | 3.5
68th
|
3.9
73rd
|
7.1
89th
|
| Beneish M-score | −2.48
69th
|
−2.61
54th
|
−2.73
34th
|
| Ohlson O-score | −7.53
43rd
|
−9.19
14th
|
−10.42
5th
|
| IS credit score | 54
46th
|
82
81st
|
94
92nd
|
Size (TTM)
8 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| Market cap | $218.7B
100th
|
$140.6B
97th
|
$49.7B
95th
|
| Revenue | $69.1B
97th
|
$74.2B
100th
|
$20.3B
81st
|
| EBITDA | $17.6B
100th
|
$13.4B
97th
|
$5.1B
89th
|
| Net income | $10.7B
100th
|
$8.4B
97th
|
$3.3B
92nd
|
| Free cash flow | $14.0B
100th
|
$11.6B
97th
|
$3.8B
92nd
|
| Total assets | $152.1B
100th
|
$73.6B
95th
|
$16.4B
81st
|
| Shareholders' equity | $34.5B
100th
|
$31.6B
97th
|
$9.6B
86th
|
| Employees | 264,300
89th
|
799,000
100th
|
328,062
92nd
|
Price performance
9 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| 1 day | −0.8% | +2.1% | +1.0% |
| 1 week | +2.2% | +10.8% | +14.2% |
| 1 month | −2.4% | +20.7% | +10.7% |
| 3 months | +9.0% | +58.7% | +8.3% |
| 6 months | −8.4% | +16.2% | −15.3% |
| Year to date | −19.9% | −11.1% | −32.5% |
| 1 year | −16.9% | −4.2% | −24.5% |
| 3 years, cumulative | +74.2% | −23.8% | −25.1% |
| 5 years, cumulative | +101.4% | −24.3% | −37.2% |
Technicals
4 measures| Measure | IBM | ACN | INFY |
|---|---|---|---|
| RSI 14 | 53.8 | 72.8 | 68.5 |
| From 52-week high | −30.2% | −21.1% | −59.2% |
| From 52-week low | +16.5% | +94.4% | +21.1% |
| Beta | 0.72 | 1.10 | 0.13 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17